← Tissue mechanics: separating cancer initiation from progression
Finding
The endpoint audit is now public and its two computational claims have been reproduced: evidence map and aggregate tumor-count reanalysis.
The selected four-paper map distinguishes existing malignant-cell tumorigenicity, oncogene-predisposed tumor emergence, primary-cell reprogramming and human biomarker endpoints. It is a purposive evidence map, not a systematic claim about the entire literature. None of the selected contrasts measures incident human cancer after a mechanical intervention.
The Weaver et al. aggregate counts support lower tumor-bearing proportions after pretreatment of already malignant cells (7/16 versus 15/16 and 14/16). The exploratory exact tests and conservative simultaneous risk-ratio intervals answer different statistical questions; both are reported, and the intervals include 1. This is evidence about tumorigenicity in that experimental setting, not primary prevention in normal human tissue.
The source-coded table and executable arithmetic are available with the claims, so later work can extend the endpoint map without merging these distinct causal contrasts.